Department of Paediatrics, Port Moresby General Hospital, NCD, Papua New Guinea.
School of Medicine and Health Sciences, Tarauma Campus, Port Moresby, NCD, Papua New Guinea.
J Trop Pediatr. 2019 Dec 1;65(6):583-591. doi: 10.1093/tropej/fmz017.
Oral rehydration solution (ORS) is the mainstay of treatment of acute watery diarrhoea, but it is underutilized in many hospitals, resulting in children with moderate degrees of dehydration being unnecessarily hospitalized and receiving intravenous fluids. We aimed to assess the utility of an ORS tolerance test on initial presentation to an emergency department, and determine the volume of ORS a child with diarrhoea and moderate dehydration needed to tolerate to be successfully managed at home. One hundred and twenty-nine children with acute watery diarrhoea and moderate dehydration were given ORS and observed in a Children's Emergency Department (CED) over a period of 2-4 h. Patients were admitted, kept in the CED for further management or discharged, based on the assessment of oral intake and the clinical judgement of the treating health workers. Seventy-nine (61.2%) patients tolerated ORS well. They drank a median [interquartile range (IQR)] of 24.4 ml (IQR 12.5-28.8) ml/kg, were judged to have passed the ORS test and were discharged to continue oral rehydration treatment at home. At follow-up on days 2 and 5, 63/79 (79.7%) children had improved, were adequately hydrated and the diarrhoea had reduced. Sixteen of the 79 (20.3%) failed oral home treatment, with persisting diarrhoea, vomiting, hypokalaemia and/or weakness. The 63 who succeeded had tolerated a median of 25.8 (IQR 18.4-30.0) ml/kg of ORS in the CED, whilst the 16 who failed oral home treatment had tolerated 11.1 (IQR 9.1-23.0) ml/kg ORS (p < 0.001).
口服补液盐(ORS)是治疗急性水样腹泻的主要方法,但在许多医院的使用率都较低,导致许多中度脱水的患儿不必要地住院并接受静脉补液。我们旨在评估在急诊科初次就诊时进行 ORS 耐受性测试的效用,并确定患有腹泻和中度脱水的儿童需要耐受多少 ORS 才能在家中成功管理。129 名患有急性水样腹泻和中度脱水的儿童在儿童急诊科(CED)接受 ORS 治疗,并在 2-4 小时内进行观察。根据口服摄入量的评估和治疗卫生工作者的临床判断,将患者收治入院、继续在 CED 接受治疗或出院。79 名(61.2%)患者对 ORS 耐受良好。他们平均(四分位距 [IQR])饮用 24.4ml(IQR 12.5-28.8)ml/kg,判断通过 ORS 测试并出院回家继续口服补液治疗。在第 2 天和第 5 天的随访中,63/79(79.7%)名儿童病情有所改善,得到充分水化,腹泻症状减轻。79 名患者中有 16 名(20.3%)口服家庭治疗失败,持续腹泻、呕吐、低钾血症和/或虚弱。63 名成功的患者在 CED 中平均耐受了 25.8(IQR 18.4-30.0)ml/kg 的 ORS,而 16 名口服家庭治疗失败的患者仅耐受了 11.1(IQR 9.1-23.0)ml/kg ORS(p<0.001)。